Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
TREX1 acts in concert with the SET complex in granzyme A-mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutières syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P = 4.1 x 10(-7)). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREX1 mutations have been identified in SLE115 and familial chilblain lupus116, implicating TREX1 as a safeguard against autoimmune inflammation.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [115]
Citations
Cites
Recognition of Cytosolic DNA Activates an IRF3-Dependent Innate Immune Response
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.003 · Cited by 1,008
Crow, Y. J., Hayward, B. E., Parmar, R., Robins, P., Leitch, A., Ali, M., Black, D. N., van Bokhoven, H., Brunner, H. G., Hamel, B. C., et al. (2006) · Nature Genetics · doi:10.1038/ng1845 · Cited by 903
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789
Mutation of DNASE1 in people with systemic lupus erythematosus
Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 596
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages
Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., Yoshikawa, H., & Nagata, S. (2006) · Nature · doi:10.1038/nature05245 · Cited by 470
Rice, G., Newman, W. G., Dean, J., Patrick, T., Parmar, R., Flintoff, K., Robins, P., Harvey, S., Hollis, T., O’Hara, A., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513443 · Cited by 410
Self-citationMorita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., Daly, G., Lindahl, T., & Barnes, D. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6719-6727.2004 · Cited by 380
Mendell, J. T., & Dietz, H. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00583-9 · Cited by 289
Role and fate of PML nuclear bodies in response to interferon and viral infections
Regad, T., & Chelbi-Alix, M. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204854 · Cited by 281
Mazur, D. J., & Perrino, F. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19655 · Cited by 276
Self-citation
Cited by
Items 101–200 of 728
Lazzaretto, B., & Fadeel, B. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800159 · Cited by 161
Catalina, M. D., Owen, K. A., Labonte, A. C., Grammer, A. C., & Lipsky, P. E. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102359 · Cited by 155
Demirkaya, E., Şahin, S., Romano, M., Zhou, Q., & Aksentijevich, I. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030712 · Cited by 170
Riedl, M., Fakhouri, F., Quintrec, M. L., Noone, D. G., Jungraithmayr, T., Frémeaux‐Bacchi, V., & Licht, C. P. B. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1376153 · Cited by 156
Goulielmos, G. N., Zervou, M. I., Vazgiourakis, V., Ghodke‐Puranik, Y., Garyfallos, A., & Niewold, T. B. (2018) · Gene · doi:10.1016/j.gene.2018.05.041 · Cited by 157
PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing
Gavin, A. L., Huang, D., Huber, C., Mårtensson, A., Tardif, V., Skog, P. D., Blane, T. R., Thinnes, T. C., Osborn, K., Chong, H. S., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0179-y · Cited by 144
Translating nucleic acid-sensing pathways into therapies
Junt, T., & Barchet, W. (2015) · Nature reviews. Immunology · doi:10.1038/nri3875 · Cited by 164
“Phenotypic overlap with SLE and genetic association of some causative genes with SLE 106 suggest that type I interferonopathies probably belong to the same group of IFN-associated inflammatory diseases .”
Autoimmunity and primary immunodeficiency: two sides of the same coin?
Schmidt, R. E., Grimbacher, B., & Witte, T. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.198 · Cited by 163
Self-citationMonocyte and Macrophage Abnormalities in Systemic Lupus Erythematosus
Li, Y., Lee, P. Y., & Reeves, W. H. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0093-y · Cited by 152
“Furthermore, these effects on cytokine production may be augmented by the increased ratio of activating-to-inhibitory FccRs (Kavai and Szegedi 2007) and/or delayed removal of endogenous nucleic acids secondary to deficiency of serum nucleases in lupus patients (Lee-Kirsch et al. 2007).”
BackgroundTrex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes
Hasan, M., Koch, J., Rakheja, D., Pattnaik, A. K., Brugarolas, J., Dozmorov, I., Levine, B., Wakeland, E. K., Lee-Kirsch, M. A., & Yan, N. (2013) · Nature Immunology · doi:10.1038/ni.2475 · Cited by 142
“TREX1 mutations in humans are associated with a spectrum of autoimmune and inflammatory phenotypes including Aicardi-Goutières syndrome (AGS, an inflammatory brain disease that mimics the symptoms of congenital viral infection 13, 14 ) , systemic lupus erythematosus (SLE), familial chilbain lupus (FCL) and retinal vas…”
BackgroundSelf-citationAntimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs
An, J., Minie, M., Sasaki, T., Woodward, J. J., & Elkon, K. B. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-043015-123453 · Cited by 140
Recent insights into the genetic basis of systemic lupus erythematosus
Rullo, O. J., & Tsao, B. P. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202351 · Cited by 164
Chilblain lupus erythematosus—a review of literature
Hedrich, C. M., Fiebig, B., Hauck, F. H., Sallmann, S., Hahn, G., Pfeiffer, C., Heubner, G., & Gahr, M. L. (2008) · Clinical Rheumatology · doi:10.1007/s10067-008-0942-9 · Cited by 139
“These novel findings indicate that certain rare mutations in TREX1 can result in a dominant phenotype with symptoms of familial CHLE, SLE or AGS [5, 6, 11].”
BackgroundSelf-citationSelf-DNA, STING-dependent signaling and the origins of autoinflammatory disease
Ahn, J., & Barber, G. N. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.10.009 · Cited by 144
Review of recent genome‐wide association scans in lupus
Graham, R. R., Hom, G., Ortmann, W., & Behrens, T. W. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02096.x · Cited by 135
Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective
Zhang, H., You, Q., & Xu, X. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01039 · Cited by 155
Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity
Raj, P., Rai, E., Song, R., Khan, S., Wakeland, B. E., Viswanathan, K., Arana, C., Liang, C., Zhang, B., Dozmorov, I., et al. (2016) · eLife · doi:10.7554/elife.12089 · Cited by 133
“Although it is clear that rare alleles contribute to disease susceptibility in small subsets of patients (Hunt et al., 2013; Lee-Kirsch et al., 2007; Tang et al., 2014; Mitchell et al., 2002), recent analytical studies have firmly established that common disease alleles are responsible for the bulk…”
BackgroundEmerging concepts of type I interferons in SLE pathogenesis and therapy
Psarras, A., Wittmann, M., & Vital, E. M. J. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00826-z · Cited by 191
Type I interferons in Sjögren's syndrome
Yao, Y., Liu, Z., Jallal, B., Shen, N., & Rönnblom, L. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.10.006 · Cited by 133
Gonçalves, A., Karayel, E., Rice, G., Bennett, K. L., Crow, Y. J., Superti‐Furga, G., & Bürckstümmer, T. (2012) · Human Mutation · doi:10.1002/humu.22087 · Cited by 154
“Mutations in TREX1, encoding the 3′ repair exonuclease 1, cause AGS and the autoimmune disorder systemic lupus erythematosus, either by directly abolishing DNase activity or by mislocalization of TREX1 through disruption of the C-terminal transmembrane domain that anchors TREX1 to the outer membrane of the endoplasmat…”
BackgroundNew roles for the major human 3′-5′ exonuclease TREX1 in human disease
Kavanagh, D., Spitzer, D., Kothari, P. H., Shaikh, A., Liszewski, M. K., Richards, A., & Atkinson, J. P. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6162 · Cited by 132
Type I interferonopathies in pediatric rheumatology
Volpi, S., Picco, P., Caorsi, R., Candotti, F., & Gattorno, M. (2016) · Pediatric Rheumatology · doi:10.1186/s12969-016-0094-4 · Cited by 131
“2–2 % in the adult SLE population [44–46] and have been linked to a particular form of SLE presenting with skin lesions of the extremities induced by cold exposure, called chilblains (CHBL1, OMIM610448) [47–49].”
BackgroundType I Interferon and Systemic Lupus Erythematosus
Elkon, K. B., & Stone, V. V. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0045 · Cited by 141
An, J., Woodward, J. J., Lai, W., Minie, M., Sun, X., Tanaka, L., Snyder, J. M., Sasaki, T., & Elkon, K. B. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40559 · Cited by 130
The STING pathway and regulation of innate immune signaling in response to DNA pathogens
Ishikawa, H., & Barber, G. N. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0605-2 · Cited by 144
Lehtinen, D. A., Harvey, S. E., Mulcahy, M. J., Hollis, T., & Perrino, F. W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806155200 · Cited by 143
Self-citationGene-function studies in systemic lupus erythematosus
Crispín, J. C., Hedrich, C. M., & Tsokos, G. C. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.78 · Cited by 130
The genetics of type I interferon in systemic lupus erythematosus
Bronson, P. G., Chaivorapol, C., Ortmann, W. A., Behrens, T. W., & Graham, R. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.07.008 · Cited by 130
Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus
Ravenscroft, J. C., Suri, M., Rice, G. I., Szynkiewicz, M., & Crow, Y. J. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33778 · Cited by 122
“Of further note, heterozygous mutations in TREX1 represent the single most common cause of SLE identified to date [Lee-Kirsch et al., 2007b].”
BackgroundTargeting the TLR9–MyD88 pathway in the regulation of adaptive immune responses
Huang, X., & Yang, Y. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.501333 · Cited by 121
“SLE patients often have mutations in genes encoding DNA nucleases including DNase-I [88], DNase-II [89], and TREX1 [90], which result in accumulation of self DNA.”
BackgroundBengtsson, A. A., & Rönnblom, L. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.10.003 · Cited by 140
Biochemistry, Cell Biology, and Pathophysiology of the Innate Immune cGAS–cGAMP–STING Pathway
Ritchie, C., Carozza, J. A., & Li, L. (2022) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-040320-101629 · Cited by 128
Rubicz, R. C., Yolken, R. H., Drigalenko, E. I., Carless, M. A., Dyer, T. D., Bauman, L., Melton, P. E., Kent, J. W., Harley, J. B., Curran, J. E., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003147 · Cited by 124
Aicardi‐Goutières syndrome: an important Mendelian mimic of congenital infection
Crow, Y. J., & Livingston, J. H. (2008) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2008.02062.x · Cited by 119
An autoimmune disease prevented by anti-retroviral drugs
Beck-Engeser, G. B., Eilat, D., & Wabl, M. (2011) · Retrovirology · doi:10.1186/1742-4690-8-91 · Cited by 117
“Furthermore, mutations in TREX1 represent the single most common cause of monogenic SLE identified to date [7].”
BackgroundLee, M. N., Roy, M., Ong, S.-E., Mertins, P., Villani, A.-C., Li, W., Dotiwala, F., Sen, J., Doench, J. G., Orzalli, M. H., et al. (2013) · Nature Immunology · doi:10.1038/ni.2509 · Cited by 117
Self-citationCrow, Y. J. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00031-9 · Cited by 126
Paediatric-onset systemic lupus erythematosus
Malattia, C., & Martini, A. (2013) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2013.07.007 · Cited by 130
Grimbacher, B., Warnatz, K., Yong, P. F. K., Korganow, A., & Peter, H. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.11.004 · Cited by 127
“It started with the identification of mutations in genes encoding the intracellular nuclease TREX1 (the most abundant 39 to 59 DNA exonuclease), followed by RNase H2 (digests DNA:RNA hybrids) and SAMHD1 (a putative nuclease), all causing the Aicardi-Goutieres syndrome in children.(41,43,142-145) Aicardi-Goutieres synd…”
Pathogenic mechanisms in systemic lupus erythematosus
Perl, A. (2010) · Autoimmunity · doi:10.3109/08916930903374741 · Cited by 114
Rosenbaum, J. T., Sibley, C. H., & Lin, P. (2016) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000271 · Cited by 115
A Mechanism for the Inhibition of DNA-PK-Mediated DNA Sensing by a Virus
Peters, N., Ferguson, B. J., Mazzon, M., Fahy, A. S., Krysztofinska, E., Arribas-Bosacoma, R., Pearl, L. H., Ren, H., & Smith, G. L. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003649 · Cited by 117
Immune Diseases Associated with TREX1 and STING Dysfunction
Yan, N. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0086 · Cited by 110
Ramesh, V., BERNARDI, B., Stafa, A., Garone, C., Franzonı, E., Abinun, M., Mitchell, P. D., Mitra, D., Friswell, M., Nelson, J. W., et al. (2010) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2010.03727.x · Cited by 120
Lupus Nephritis: An Overview of Recent Findings
Salgado, A. D. Z., & Herrera-Díaz, C. (2012) · Autoimmune Diseases · doi:10.1155/2012/849684 · Cited by 122
“3 TREX1 rs72556554 European, Asian, Hispanic, African 25 [61, 62]”
Hasan, M., Fermaintt, C. S., Gao, N., Sakai, T., Miyazaki, T., Jiang, S., Li, Q.-Z., Atkinson, J. P., Morse, H. C., Lehrman, M. A., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.022 · Cited by 108
“TREX1 protein has an exonuclease domain at the N terminus and an ER localization domain at the C termi- nus, containing a single-pass transmembrane (TM) motif tail- anchoring TREX1 on the ER (Lee-Kirsch et al., 2007; Lindahl et al., 2009).”
BackgroundGenetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype
Ceccarelli, F., Perricone, C., Borgiani, P., Ciccacci, C., Rufini, S., Cipriano, E., Alessandri, C., Spinelli, F., Scavalli, A. S., Novelli, G., et al. (2015) · Journal of Immunological Research · doi:10.1155/2015/745647 · Cited by 102
Shaping the spectrum - From autoinflammation to autoimmunity.
Hedrich, C. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.03.002 · Cited by 98
Systemic Lupus Erythematosus – A Disease with A Dysregulated Type I Interferon System
Hagberg, N., & Rönnblom, L. (2015) · Scandinavian Journal of Immunology · doi:10.1111/sji.12330 · Cited by 111
Hedrich, C. M., Smith, E. M. D., & Beresford, M. W. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2018.02.001 · Cited by 119
“Of note, some of the disease-associated risk alleles are located in or around genes that can also cause monogenic SLE when carrying loss-of-function mutations (e.g. complement genes, TREX1, etc.).”
BackgroundInfluentialGenetic Factors Predisposing to Systemic Lupus Erythematosus and Lupus Nephritis
Ramos, P. S., Brown, E. E., Kimberly, R. P., & Langefeld, C. D. (2010) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2010.01.007 · Cited by 125
Seldin, M. F. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.08.015 · Cited by 121
Bélot, A., Rice, G., Omarjee, O., Rouchon, Q., Smith, E. M. D., Moreews, M., Tusseau, M., Frachette, C., Bournhonesque, R., Thielens, N. M., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(19)30142-0 · Cited by 113
Review: Cell Death, Nucleic Acids, and Immunity
Elkon, K. B. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40452 · Cited by 108
Cause and consequences of the activated type I interferon system in SLE
Eloranta, M., & Rönnblom, L. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1421-4 · Cited by 110
“The most well-known monogenic defects associated with a high risk for SLE are loss-of-function mutations in C1q and C4, encoding components of the classical complement pathway, and in the 3′-5′ exonuclease TREX1 [44, 45], the latter leading to accumulation of intracellular DNA that triggers type I IFN production.”
Wang, J., Dai, M., Cui, Y., Hou, G., Deng, J., Gao, X., Liao, Z., Liu, Y., Meng, Y., Wu, L., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40576 · Cited by 126
Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus
Shrivastav, M., & Niewold, T. B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00319 · Cited by 109
Monteith, A. J., Kang, S., Scott, E., Hillman, K., Rajfur, Z., Jacobson, K., Costello, M. J., & Vilen, B. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513943113 · Cited by 99
“Lee-Kirsch MA, et al. (2007) Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus.”
BackgroundSTING palmitoylation as a therapeutic target
Hansen, A. L., Mukai, K., Schopfer, F. J., Taguchi, T., & Holm, C. K. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0205-5 · Cited by 108
Collaboration, Genetic Associations, and Lupus Erythematosus
Crow, M. K. (2008) · New England Journal of Medicine · doi:10.1056/nejme0800096 · Cited by 98
The genetics of human autoimmune disease
Invernizzi, P., & Gershwin, M. E. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.07.008 · Cited by 103
Recent advances in the genetics of systemic lupus erythematosus
Thibault Flesher, D. L., Sun, X., Behrens, T. W., Graham, R. R., & Criswell, L. A. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.8 · Cited by 93
The contribution of macrophages to systemic lupus erythematosus
Ma, C., Xia, Y., Yang, Q., & Zhao, Y. (2019) · Clinical Immunology · doi:10.1016/j.clim.2019.06.009 · Cited by 100
Sensing of transposable elements by the antiviral innate immune system
Gázquez-Gutiérrez, A., Witteveldt, J., Heras, S. R., & Macías, S. (2021) · RNA · doi:10.1261/rna.078721.121 · Cited by 109
“A link between AGS and lupus was highlighted by the discovery of TREX1, SAMHD1, RNASEH2A/B/C and IFIH1 mutations in SLE patients (Lee-Kirsch et al. 2007; Ravenscroft et al. 2011; Cunninghame Graham et al. 2011; Günther et al. 2015).”
BackgroundInfluentialThe SET Complex Acts as a Barrier to Autointegration of HIV-1
Yan, N., Cherepanov, P., Daigle, J. E., Engelman, A., & Lieberman, J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000327 · Cited by 92
Self-citationJärvinen, T. M., Hellquist, A., Koskenmies, S., Einarsdóttir, E., Koskinen, L. L. E., Jeskanen, L., Berglind, L., Panelius, J., Hasan, T., Ranki, A., et al. (2009) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.00982.x · Cited by 95
Self-citationAcute microglia ablation induces neurodegeneration in the somatosensory system
Rubino, S. J., Mayo, L., Wimmer, I., Siedler, V., Brunner, F., Hametner, S., Madi, A., Lanser, A., Moreira, T., Donnelly, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05929-4 · Cited by 91
Quanz, M., Herbette, A., Sayarath, M., de Koning, L., Dubois, T., Sun, J.-S., & Dutreix, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.320887 · Cited by 90
Translating the Untranslated Region
Schwerk, J., & Savan, R. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500756 · Cited by 89
Orcesi, S., Piana, R. L., & Fazzi, E. M. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn049 · Cited by 95
Recent findings on genetics of systemic autoimmune diseases
Delgado-Vega, A. M., Sánchez, E., Löfgren, S. E., Castillejo-López, C., & Alarcón-Riquelme, M. E. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.09.002 · Cited by 97
“3 TREX1 rs72556554, R114H and other 11 nonsynonimous substitutions European [16]”
Clinical reviews in allergy and immunology
Leung, D. Y. M., Ledford, D. K., Wechsler, M. E., Fulkerson, P. C., Bochner, B. S., Gauvreau, G. M., Gleich, G. J., Henkel, T., Kolbeck, R., Mathur, S. K., et al. (2012) · Cited by 87
Almlöf, J. C., Nystedt, S., Leonard, D., Eloranta, M., Grosso, G., Sjöwall, C., Bengtsson, A. A., Jönsen, A., Gunnarsson, I., Svenungsson, E., et al. (2019) · Human Genetics · doi:10.1007/s00439-018-01966-7 · Cited by 95
Cheng, M., & Anderson, M. S. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074953 · Cited by 93
“5–2% of SLE patients (58, 59), upholding the paradigm that rare variants cause disease in a subset of patients with common heterogeneous disorders (see sidebar).”
BackgroundOpportunities and limitations of B cell depletion approaches in SLE
Stockfelt, M., Teng, Y. K. O., & Vital, E. M. J. (2025) · Nature Reviews Rheumatology · doi:10.1038/s41584-024-01210-9 · Cited by 99
“Processes that increase the extracellular availability of these autoantigens are likely to precede the accumulating loss of B cell tolerance 145,146 .”
InfluentialWang, Y., Fu, Z., Li, X., Liang, Y., Pei, S., Hao, S., Zhu, Q., Yu, T., Pei, Y., Yuan, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.02.003 · Cited by 84
Induction of type I IFNs by intracellular DNA‐sensing pathways
Cavlar, T., Ablasser, A., & Hornung, V. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2012.11 · Cited by 84
Type I interferon-mediated autoinflammation and autoimmunity
Kretschmer, S., & Lee‐Kirsch, M. A. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.09.003 · Cited by 88
Self-citationRNA degradation in antiviral immunity and autoimmunity
Rigby, R. E., & Rehwinkel, J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.001 · Cited by 84
Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants
Vinuesa, C. G., Shen, N., & Ware, T. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00732-x · Cited by 105
Gender balance in patients with systemic lupus erythematosus
Margery-Muir, A. A., Bundell, C. S., Nelson, D. J., Groth, D., & Wetherall, J. D. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.01.007 · Cited by 91
The Lupus Family Registry and Repository
Rasmussen, A., Sevier, S. T., Kelly, J. A., Glenn, S. B., Aberle, T., Cooney, C. M. M., Grether, A., James, E. M., Ning, J., Tesiram, J., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq302 · Cited by 79
Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis
Bélot, A., & Cimaz, R. (2012) · Pediatric Rheumatology · doi:10.1186/1546-0096-10-21 · Cited by 98
“5 to 2% heterozygosity, thus making TREX1 mutations the most frequent form of monogenic lupus [26,27].”
BackgroundMigraine and Genetic and Acquired Vasculopathies
Stam, A., Haan, J., van den Maagdenberg, A., Ferrari, M. D., & Terwindt, G. M. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01940.x · Cited by 83
Loss of Trex1 in Dendritic Cells Is Sufficient To Trigger Systemic Autoimmunity
Peschke, K., Achleitner, M., Frenzel, K., Gerbaulet, A., Ada, S. R., Zeller, N., Lienenklaus, S., Lesche, M., Poulet, C., Naumann, R., et al. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600722 · Cited by 79
cGAS-STING Pathway Does Not Promote Autoimmunity in Murine Models of SLE
Motwani, M., McGowan, J. D., Antonovitch, J., Gao, K. M., Jiang, Z., Sharma, S., Baltus, G. A., Nickerson, K. M., Marshak‐Rothstein, A., & Fitzgerald, K. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.605930 · Cited by 90
“By contrast, mice homozygous for C-terminal frameshift mutation, D272fs, previously associated with SLE (27), exhibit no clinical manifestations of disease but do develop high autoantibody titers primarily directed against non-nuclear antigens, and thus distinct from the autoantibody specificities associated with SLE…”
BackgroundThe innate immune response to DNA
Vilaysane, A., & Muruve, D. A. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.006 · Cited by 89
Gao, L., Bird, A. K., Meednu, N., Dauenhauer, K., Liesveld, J., Anolik, J., & Looney, R. J. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40142 · Cited by 78
Rheumatoid arthritis: a view of the current genetic landscape
Coenen, M. J. H., & Gregersen, P. K. (2008) · Genes and Immunity · doi:10.1038/gene.2008.77 · Cited by 89
“The investigation of the contribution of rare variation to risk for common complex disorders is challenging, and there is currently only one clear example of this for the common autoimmune disorders”
BackgroundSingle-stranded nucleic acids promote SAMHD1 complex formation
Tüngler, V., Staroske, W., Kind, B., Dobrick, M., Kretschmer, S., Schmidt, F., Krug, C., Lorenz, M., Chara, O., Schwille, P., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-0995-3 · Cited by 85
“R290H affects a highly conserved residue within the HD domain region and was found along with Q548X in an AGS patient who also presented with SLE.”
BackgroundInfluentialSelf-citationChristmann, M., Tomicic, M. T., Aasland, D., Berdelle, N., & Kaina, B. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq455 · Cited by 77
Brooks, P. J., Cheng, T., & Cooper, L. D. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.01.017 · Cited by 88
“In contrast, other heterozygous TREX1 mutations do not result in neurologic disease, but instead cause the autoimmune disease systemic lupus erythromatosus (SLE) [55], and a dominant negative TREX1 mutation results in the related disorder familial chilblain lupus (FCL) [56,57].”
BackgroundAicardi–Goutières syndrome: a model disease for systemic autoimmunity
Lee‐Kirsch, M. A., Wolf, C., & Günther, C. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12160 · Cited by 83
Self-citationEllyard, J. I., Jerjen, R., Martin, J. L., Lee, A. Y. S., Field, M. A., Jiang, S., Cappello, J. Y., Naumann, S. K., Andrews, T. D., Scott, H. S., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38824 · Cited by 85
“One study sequencing TREX1 in a cohort of 417 SLE patients identified 9 variants, none of which were the variant identified in this study (9).”
BackgroundNucleic acid driven sterile inflammation
Ablasser, A., Hertrich, C., Wassermann, R., & Hornung, V. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.01.003 · Cited by 83
Cisneros, G. A., Perera, L., Schaaper, R. M., Pedersen, L. C., London, R. E., Pedersen, L. G., & Darden, T. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja8082818 · Cited by 75
Dominant Mutations of the TREX1 Exonuclease Gene in Lupus and Aicardi-Goutières Syndrome
Fye, J. M., Orebaugh, C. D., Coffin, S. R., Hollis, T., & Perrino, F. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276287 · Cited by 84
Self-citationNakaya, Y., Lilue, J., Stavrou, S., Moran, E. A., & Ross, S. R. (2017) · mBio · doi:10.1128/mbio.00944-17 · Cited by 74
Innate Immune Activation and Thyroid Autoimmunity
Kawashima, A., Tanigawa, K., Akama, T., Yoshihara, A., Ishii, N., & Suzuki, K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1568 · Cited by 79
Monogenic lupus: it's all new!
Costa‐Reis, P., & Sullivan, K. E. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.10.008 · Cited by 87
Metadata
- Authors
- Lee-Kirsch, M. A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.-A., de Silva, U., Bailey, S. L., Witte, T., Vyse, T. J., Kere, J., Pfeiffer, C., Harvey, S., Wong, A., Koskenmies, S., Hummel, O., Rohde, K., Schmidt, R. E., Dominiczak, A. F., Gahr, M., Hollis, T., Perrino, F. W., Lieberman, J., & Hübner, N.
- Affiliations
- Max Delbrück Center (DE)
- Harvard University (US)
- Technische Universität Dresden (DE)
- Wake Forest University Health Sciences (US)
- Medizinische Hochschule Hannover (DE)
- Hammersmith Hospital (GB)
- Karolinska Institutet (SE)
- Klinik und Poliklinik für Dermatologie (DE)
- University of Helsinki (FI)
- University of Glasgow (GB)
- Corresponding author
- Lee, Young-Ae
- Hübner, Norbert
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-07-29
- Volume
- 39
- Issue
- 9
- Pages
- 1065-1067
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2043959346
- Semantic Scholar
- 443992a86650d6f5f9c909d94b91ccce78822316
- Cited by
- 730
- References
- 15
- Citations by year
- 2026: 21 · 2025: 31 · 2024: 57 · 2023: 32 · 2022: 30 · 2021: 36 · 2020: 23 · 2019: 44 · 2018: 34 · 2017: 39 · 2016: 48 · 2015: 43 · 2014: 38 · 2013: 57 · 2012: 48
- FWCI
- 25.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM069962, GM 069962)
- National Institute of Allergy and Infectious Diseases (AI45587)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREX1, systemic lupus erythematosus, 3'-5' exonuclease, Aicardi-Goutières syndrome, monoallelic variants, frameshift mutation, missense mutations, 3'UTR variant, subcellular targeting, genetic susceptibility
- MeSH terms
- Exodeoxyribonucleases, Gene Frequency, Genotype, HeLa Cells, Humans, Lupus Erythematosus, Cutaneous, Mutation, Phosphoproteins, Endosomes, Recombinant Proteins, Frameshift Mutation, Protein Structure, Tertiary, Genetic Predisposition to Disease, Mutation, Missense, 3' Untranslated Regions, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.